Literature DB >> 2885883

Biphasic effect of L-5-HTP in the Vogel conflict model.

S Hjorth, B Söderpalm, J A Engel.   

Abstract

The effect of L-5-HTP (25 400 mg/kg IP) following inhibition of the peripheral aromatic amino acid decarboxylase by means of benserazide (25 mg/kg IP) was investigated in a test modified from Vogel's drinking conflict model. At 50 mg/kg an anti-conflict action was detected, while higher doses (100-400 mg/kg) decreased punished responding. A lower dose (25 mg/kg) had no effect. Non-specific effects--such as alterations in muscle tone, in motivation to drink or in the sensitivity to electrical shock--could not explain the anxiolytic- and anxiogenic-like actions of 50 and 100 mg/kg, respectively. The bi-phasic effect of L-5-HTP is discussed in terms of different subpopulations of central serotoninergic receptors, possibly exerting opposing influences on conflict responding. The study emphasises the importance of 5-HT mechanisms in anxiety, and the possibility of finding novel anxiolytics among drugs selectively affecting central 5-HT neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885883     DOI: 10.1007/bf00215486

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  5-Hydroxytryptamine and punishment.

Authors:  N C Tye; B J Everitt; S D Iversen
Journal:  Nature       Date:  1977-08-25       Impact factor: 49.962

2.  The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior.

Authors:  I Geller; K Blum
Journal:  Eur J Pharmacol       Date:  1970-03       Impact factor: 4.432

Review 3.  An animal behavior model for studying central serotonergic synapses.

Authors:  B L Jacobs
Journal:  Life Sci       Date:  1976-09-15       Impact factor: 5.037

4.  8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.

Authors:  L E Arvidsson; U Hacksell; J L Nilsson; S Hjorth; A Carlsson; P Lindberg; D Sanchez; H Wikstrom
Journal:  J Med Chem       Date:  1981-08       Impact factor: 7.446

5.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

6.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

7.  Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

Authors:  J Traber; M A Davies; W U Dompert; T Glaser; T Schuurman; P R Seidel
Journal:  Brain Res Bull       Date:  1984-06       Impact factor: 4.077

8.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.

Authors:  H Gozlan; S El Mestikawy; L Pichat; J Glowinski; M Hamon
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

9.  L-5-hydroxytryptophan in the treatment of anxiety disorders.

Authors:  R S Kahn; H G Westenberg
Journal:  J Affect Disord       Date:  1985 Mar-Apr       Impact factor: 4.839

10.  Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.

Authors:  C D Kilts; R L Commissaris; J J Cordon; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  3 in total

1.  The yohimbine-induced anticonflict effect in the rat, Part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms.

Authors:  A Söderpalm; O Blomqvist; B Söderpalm
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Does the PCPA induced anticonflict effect involve activation of the GABAA/benzodiazepine chloride ionophore receptor complex?

Authors:  B Söderpalm; J A Engel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

Authors:  H G Westenberg; J A den Boer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.